Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00523393Phase 4Unknown
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Heidelberg University. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00523393.